Xylem Inc. Files 8-K for Reg FD and Financials

Ticker: XYL · Form: 8-K · Filed: Mar 8, 2024 · CIK: 1524472

Xylem Inc. 8-K Filing Summary
FieldDetail
CompanyXylem Inc. (XYL)
Form Type8-K
Filed DateMar 8, 2024
Risk Levellow
Pages3
Reading Time4 min
Key Dollar Amounts$0.01
Sentimentneutral

Sentiment: neutral

Topics: regulatory-filing, financial-reporting

Related Tickers: XYL

TL;DR

XYL filed an 8-K on March 8th, confirming office location and stock exchange listing.

AI Summary

Xylem Inc. filed an 8-K on March 8, 2024, to report on Regulation FD disclosures and financial statements. The filing confirms Xylem's principal executive offices are located at 301 Water Street SE, Washington, DC 20003, and its common stock is traded on the New York Stock Exchange under the symbol XYL.

Why It Matters

This 8-K filing provides essential updates on Xylem's regulatory compliance and financial reporting, offering transparency to investors.

Risk Assessment

Risk Level: low — This is a routine filing for regulatory and financial reporting purposes, not indicating any specific new risks.

Key Players & Entities

  • Xylem Inc. (company) — Registrant
  • March 8, 2024 (date) — Date of Report
  • 301 Water Street SE, Washington, DC 20003 (location) — Principal executive offices
  • XYL (ticker) — Trading Symbol
  • New York Stock Exchange (company) — Exchange

FAQ

What is the primary purpose of this 8-K filing by Xylem Inc.?

The primary purpose of this 8-K filing is to report on Regulation FD disclosures and financial statements and exhibits.

When was the earliest event reported in this filing?

The earliest event reported in this filing was on March 8, 2024.

What is the address of Xylem Inc.'s principal executive offices?

The address of Xylem Inc.'s principal executive offices is 301 Water Street SE, Washington, DC 20003.

On which stock exchange is Xylem Inc.'s common stock registered?

Xylem Inc.'s common stock is registered on the New York Stock Exchange.

What is the trading symbol for Xylem Inc.'s common stock?

The trading symbol for Xylem Inc.'s common stock is XYL.

Filing Stats: 953 words · 4 min read · ~3 pages · Grade level 13.7 · Accepted 2024-03-08 09:34:04

Key Financial Figures

  • $0.01 — ich registered Common Stock, par value $0.01 per share XYL New York Stock Exchange

Filing Documents

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure On May 24, 2023, Xylem Inc. (the "Company") completed the acquisition of Evoqua Water Technologies Corp. ("Evoqua"). For the periods ended June 30, 2023, September 30, 2023 and December 31, 2023, the Company's reportable segments included legacy Evoqua's Integrated Solutions and Services ("ISS") segment as a new and fourth reportable segment. On December 13, 2023, the Company announced a change to its reportable segments effective January 1, 2024. As a result, for financial statement periods ending after January 1, 2024, the Company will report the financial position and results of operations of its ISS segment together with the dewatering business, formerly within the Water Infrastructure segment, and the assessment services business, formerly within the Measurement and Control Solutions segment, in a new segment that will be referred to as Water Solutions and Services. The Company's Water Infrastructure reportable segment will no longer include the results of the dewatering business, and the Company's Measurement and Control Solutions reportable segment will no longer include the results of the assessment services business. The Company's Applied Water reportable segment will remain unchanged. The Company believes this organizational redesign, which creates its services platform, will deliver a unified customer experience and accelerate the growth of its services offerings. For informational purposes and to provide investors with historical information on a basis consistent with its new reporting structure, the Company has provided certain recast financial information reflecting the new reportable segments. The recast financial information reflects depreciation, amortization and share-based compensation specifically identified to the segments which were previously reported within Corporate and other and Regional selling locations as part of an overall allocation. These changes have no impact on the Company's historical consol

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits (d) Exhibits. Exhibit No. Description 99.1 Recast segment information of Xylem Inc. (furnished pursuant to Item 7.01) 104.0 The cover page from Xylem Inc.'s Form 8-K, formatted in Inline XBRL (included as Exhibit 101).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. XYLEM INC. Date: March 8, 2024 By: /s/ William K. Grogan William K. Grogan Senior Vice President and Chief Financial Officer (Authorized Officer of Registrant)

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.